Athira Pharma Inc (ATHA)

$3.16 0.03 (0.96%)
16:00 EDT ATHA Stock Quote Delayed 30 Minutes

Athira Pharma (ATHA) Stock Plunges 65% on Disappointing Drug Trial Results

Athira Pharma (ATHA) stock is plummeting on Wednesday following the outcome of a Phase 2 clinical trial of fosgonimeton.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 119.50M
PE Ratio -1.53
EPS -2.07
Volume (Avg. Vol.) 115,021
Day's Range $3.08 - $3.21
52-Week Range $2.53 - $16.65
Dividend & Yield N/A (N/A)